https://doi.org/10.4081/gc.2021.9895

COMEPA (COVID-19 Medicina Policlinico Palermo): a study in hospitalized patients

Vol. 7 No. 3 (2021)
Submitted: 4 June 2021
Accepted: 2 August 2021
Published: 21 September 2021
COMEPA, COVID-19, therapy, internal medicine, prognosis.
Abstract Views: 1358
PDF: 271
HTML: 6
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The COMEPA group
nicola.veronese@unipa.it
Department of Internal Medicine and Geriatrics, University of Palermo, Italy.

Coronavirus disease 2019 (COVID-19) has dramatically changed our lives. In the past months, hospitals were saturated of patients; therefore, it is still important to have simple and standardized prognostic factors and to evaluate the efficacy and safety of medications commonly used for COVID-19. We aimed to collect data of the patients hospitalized in Internal Medicine and Geriatrics Wards at the University Hospital (Policlinico) ‘P. Giaccone’ in Palermo, Italy (COMEPA, COVID-19 Medicina Policlinico Palermo), with the main purpose of finding prognostic tools that can be easily used in clinical practice in order to identify patients hospitalized for/with COVID-19 at higher risk of negative outcomes, such as mortality, transfer to Intensive Care Unit (ICU) and institutionalization, as well as evaluating the efficacy/safety of medications commonly used for COVID-19. For reaching these aims, the medical records of approximately 600 patients will be recorded, having data on several parameters and including as outcomes mortality, ICU placement, institutionalization. With the COMEPA study, we therefore plan to update current literature, giving new data on prognostic factors and on the efficacy/safety of some medications used for COVID-19.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Jebril N. World Health Organization declared a pandemic public health menace: A systematic review of the coronavirus disease 2019 “COVID-19”, up to 26th March 2020. Available at SSRN 3566298; 2020. DOI: https://doi.org/10.2139/ssrn.3566298
Organization WH. Coronavirus disease 2019 (COVID-19): situation report, 45. 2020.
Haas LE, de Lange DW, van Dijk D, van Delden JJ. Should we deny ICU admission to the elderly? Ethical considerations in times of COVID-19. Critical Care 2020;24:1-3. DOI: https://doi.org/10.1186/s13054-020-03050-x
White DB, Lo B. A framework for rationing ventilators and critical care beds during the COVID-19 pandemic. JAMA 2020;323:1773-4. DOI: https://doi.org/10.1001/jama.2020.5046
Khullar D, Bond AM, Schpero WL. COVID-19 and the financial health of US hospitals. JAMA 2020;323:2127-8. DOI: https://doi.org/10.1001/jama.2020.6269
Birkmeyer JD, Barnato A, Birkmeyer N, et al. The impact of the COVID-19 pandemic on hospital admissions in the United States: study examines trends in US hospital admissions during the COVID-19 pandemic. Health Affairs 2020;39:2010-7. DOI: https://doi.org/10.1377/hlthaff.2020.00980
Chirico F, Nucera G, Magnavita N. Protecting the mental health of healthcare workers during the COVID-19 emergency. BJPsych Int 2021;18(1). DOI: https://doi.org/10.1192/bji.2020.39
Kozyreff G. Hospitalization dynamics during the first COVID-19 pandemic wave: sir modelling compared to Belgium, France, Italy, Switzerland and New York City data. Infect Dis Model 2021;6:398-404. DOI: https://doi.org/10.1016/j.idm.2021.01.006
Polidori MC, Maggi S, Mattace-Raso F, Pilotto A. The unavoidable costs of frailty: a geriatric perspective in the time of COVID-19. Geriatric Care 2020;6:8989. DOI: https://doi.org/10.4081/gc.2020.8989
Wynants L, Van Calster B, Collins GS, et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ 2020;369.
Guo S, Fraser MW. Propensity score analysis: Statistical methods and applications. Vol 11: SAGE publications; 2014.
Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc 1968;16:622-6. DOI: https://doi.org/10.1111/j.1532-5415.1968.tb02103.x
Distante C, Piscitelli P, Miani A. Covid-19 outbreak progression in Italian regions: approaching the peak by the end of March in northern Italy and first week of April in southern Italy. Int J Environ Res Public Health 2020;17:3025. DOI: https://doi.org/10.3390/ijerph17093025
Sanità IS. COVID-19 integrated surveillance data in Italy; 2021. Available from: https://www.epicentro.iss.it/en/coronavirus/sars-cov-2-dashboard Accessed: 05/17/2021.
Davies NG, Jarvis CI, Edmunds WJ, et al. Increased mortality in community-tested cases of SARS-CoV-2 lineage B. 1.1. 7. Nature 2021:1-5. DOI: https://doi.org/10.1101/2021.02.01.21250959
Loconsole D, Sallustio A, Accogli M, et al. Outbreak investigation of symptomatic SARS-COV-2 VOC 202012/01-lineage B. 1.1. 7 infection in healthcare workers, Italy. Clin Microbiol Infection 2021 [Epub ahead of print]. DOI: https://doi.org/10.1016/j.cmi.2021.05.007
Winck J, Scala R. Non-invasive respiratory support paths in hospitalized patients with COVID-19: proposal of an algorithm. Pulmonology 2021 [Epub ahead of print]. DOI: https://doi.org/10.1016/j.pulmoe.2020.12.005
Lechien JR, Chiesa‐Estomba CM, Radulesco T, et al. Clinical features of patients who had two COVID‐19 episodes: a European multicentre case series. J Intern Med 2021 [Epub ahead of print]. DOI: https://doi.org/10.1111/joim.13259
Veronese N, Demurtas J, Yang L, et al. Use of corticosteroids in coronavirus disease 2019 pneumonia: a systematic review of the literature. Front Medicine 2020;7:170. DOI: https://doi.org/10.3389/fmed.2020.00170
Bolzetta F, Maselli M, Formilan M, et al. Prophylactic or therapeutic doses of heparins for COVID-19 infection? A retrospective study. Aging Clin Exper Res 2021;33:213-7. DOI: https://doi.org/10.1007/s40520-020-01750-6
Okoli GN, Rabbani R, Copstein L, et al. Remdesivir for coronavirus disease 2019 (COVID-19): a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials. Infect Dis 2021:1-9. DOI: https://doi.org/10.1080/23744235.2021.1923799

How to Cite

The COMEPA group. (2021). COMEPA (COVID-19 Medicina Policlinico Palermo): a study in hospitalized patients. Geriatric Care, 7(3). https://doi.org/10.4081/gc.2021.9895

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.